AG1406 is primarily utilized in the field of cancer research due to its potential as a targeted therapeutic agent. It functions by inhibiting specific pathways that are crucial for the survival and proliferation of cancer cells, making it a promising candidate for the treatment of various malignancies. Researchers are particularly interested in its ability to selectively target tumor cells while sparing healthy tissues, which could lead to fewer side effects compared to traditional chemotherapy. Additionally, AG1406 is being studied for its role in overcoming drug resistance in certain cancers, offering a potential solution for patients who have developed resistance to standard treatments. Its application extends to preclinical studies where it is used to understand the molecular mechanisms of cancer progression and to evaluate its efficacy in combination with other anticancer drugs.